- Home
- NRDY vs TLSI Comparison
NRDY vs TLSI Comparison
Compare NRDY & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- TLSI
- Stock Information
- Founded
- NRDY 2007
- TLSI 2010
- Country
- NRDY United States
- TLSI United States
- Employees
- NRDY N/A
- TLSI N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- TLSI Medical Specialities
- Sector
- NRDY Technology
- TLSI Health Care
- Exchange
- NRDY Nasdaq
- TLSI Nasdaq
- Market Cap
- NRDY 188.8M
- TLSI 160.4M
- IPO Year
- NRDY N/A
- TLSI N/A
- Fundamental
- Price
- NRDY $1.54
- TLSI $5.02
- Analyst Decision
- NRDY Hold
- TLSI Strong Buy
- Analyst Count
- NRDY 8
- TLSI 6
- Target Price
- NRDY $1.90
- TLSI $11.75
- AVG Volume (30 Days)
- NRDY 474.2K
- TLSI 33.4K
- Earning Date
- NRDY 05-08-2025
- TLSI 05-14-2025
- Dividend Yield
- NRDY N/A
- TLSI N/A
- EPS Growth
- NRDY N/A
- TLSI N/A
- EPS
- NRDY N/A
- TLSI N/A
- Revenue
- NRDY $184,099,000.00
- TLSI $29,431,000.00
- Revenue This Year
- NRDY $3.83
- TLSI $56.00
- Revenue Next Year
- NRDY $9.45
- TLSI $52.17
- P/E Ratio
- NRDY N/A
- TLSI N/A
- Revenue Growth
- NRDY N/A
- TLSI 58.99
- 52 Week Low
- NRDY $0.73
- TLSI $3.50
- 52 Week High
- NRDY $2.46
- TLSI $10.24
- Technical
- Relative Strength Index (RSI)
- NRDY 47.27
- TLSI 34.87
- Support Level
- NRDY $1.58
- TLSI $4.66
- Resistance Level
- NRDY $1.74
- TLSI $5.40
- Average True Range (ATR)
- NRDY 0.09
- TLSI 0.37
- MACD
- NRDY 0.00
- TLSI -0.06
- Stochastic Oscillator
- NRDY 29.51
- TLSI 29.51
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.